144 related articles for article (PubMed ID: 23129228)
21. PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells.
Siu A; Virtanen C; Jongstra J
Oncotarget; 2011 Dec; 2(12):1134-44. PubMed ID: 22193779
[TBL] [Abstract][Full Text] [Related]
22. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA; Preece DM; Bentel JM
Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
[TBL] [Abstract][Full Text] [Related]
23. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.
Abdulkadir SA
Ann N Y Acad Sci; 2005 Nov; 1059():33-40. PubMed ID: 16382041
[TBL] [Abstract][Full Text] [Related]
25. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
[TBL] [Abstract][Full Text] [Related]
26. Interaction of Nkx3.1 and p27kip1 in prostate tumor initiation.
Gary B; Azuero R; Mohanty GS; Bell WC; Eltoum IE; Abdulkadir SA
Am J Pathol; 2004 May; 164(5):1607-14. PubMed ID: 15111307
[TBL] [Abstract][Full Text] [Related]
27. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
[TBL] [Abstract][Full Text] [Related]
28. RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.
Logan M; Anderson PD; Saab ST; Hameed O; Abdulkadir SA
Am J Pathol; 2013 Sep; 183(3):951-63. PubMed ID: 23867798
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.
Guan B; Pungaliya P; Li X; Uquillas C; Mutton LN; Rubin EH; Bieberich CJ
J Biol Chem; 2008 Feb; 283(8):4834-40. PubMed ID: 18077445
[TBL] [Abstract][Full Text] [Related]
30. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
Singh N; Padi SKR; Bearss JJ; Pandey R; Okumura K; Beltran H; Song JH; Kraft AS; Olive V
Mol Oncol; 2020 May; 14(5):974-990. PubMed ID: 32146726
[TBL] [Abstract][Full Text] [Related]
31. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.
Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C
Cancer Res; 2005 Aug; 65(15):6773-9. PubMed ID: 16061659
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of the oncogenic kinase Pim-1 leads to genomic instability.
Roh M; Gary B; Song C; Said-Al-Naief N; Tousson A; Kraft A; Eltoum IE; Abdulkadir SA
Cancer Res; 2003 Dec; 63(23):8079-84. PubMed ID: 14678956
[TBL] [Abstract][Full Text] [Related]
33. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
[TBL] [Abstract][Full Text] [Related]
34. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.
Gelmann EP; Steadman DJ; Ma J; Ahronovitz N; Voeller HJ; Swope S; Abbaszadegan M; Brown KM; Strand K; Hayes RB; Stampfer MJ
Cancer Res; 2002 May; 62(9):2654-9. PubMed ID: 11980664
[TBL] [Abstract][Full Text] [Related]
35. NKX3.1 homeodomain protein binds to topoisomerase I and enhances its activity.
Bowen C; Stuart A; Ju JH; Tuan J; Blonder J; Conrads TP; Veenstra TD; Gelmann EP
Cancer Res; 2007 Jan; 67(2):455-64. PubMed ID: 17234752
[TBL] [Abstract][Full Text] [Related]
36. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
[TBL] [Abstract][Full Text] [Related]
37. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
[TBL] [Abstract][Full Text] [Related]
38. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor.
Ju JH; Maeng JS; Zemedkun M; Ahronovitz N; Mack JW; Ferretti JA; Gelmann EP; Gruschus JM
J Mol Biol; 2006 Jul; 360(5):989-99. PubMed ID: 16814806
[TBL] [Abstract][Full Text] [Related]
39. Insulin receptor substrate 1 is a substrate of the Pim protein kinases.
Song JH; Padi SK; Luevano LA; Minden MD; DeAngelo DJ; Hardiman G; Ball LE; Warfel NA; Kraft AS
Oncotarget; 2016 Apr; 7(15):20152-65. PubMed ID: 26956053
[TBL] [Abstract][Full Text] [Related]
40. Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models.
Sooreshjani MA; Kamra M; Zoubeidi A; Shah K
J Biomed Sci; 2021 Oct; 28(1):68. PubMed ID: 34625072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
